Stay updated on Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page.
Latest updates to the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.0%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.0%
- Check35 days agoChange DetectedThe website has removed the 'Last Update Posted (Estimated)' section and replaced it with a definitive 'Last Update Posted' section.SummaryDifference0.0%
- Check42 days agoChange DetectedA new publication detailing a phase 3 clinical trial on pembrolizumab for high-risk cervical cancer has been added, with the last update now estimated for July 2024.SummaryDifference2%
- Check50 days agoChange DetectedThe website has been updated to version v2.10.0, adding 2 new interventions/treatments, 6 additional study numbers, and noting that the study now has 176 locations.SummaryDifference0.3%
- Check57 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.0%
Stay in the know with updates to Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page.